AMERICAN MEDICAL MARIJUANA
PHYSICIANS ASSOCIATION ENDORSES ALTERNATE HEALTHS CANAPASS
PATIENT MANAGEMENT SYSTEM
TORONTO, September 25, 2017 Alternate Health Corp (Alternate Health or the
Company) (CSE:AHG) (OTC:AHGIF), an international medical
cannabis company that uses best-in-class technology, research,
education, production and laboratories to increase the awareness,
regulatory compliance, and appropriate usage of cannabinoids in
modern medical practices, today announced that the American Medical
Marijuana Physicians Association (AMMPA) has endorsed the Companys
CanaPass patient management software.
AMMPAs commitment to physician advocacy means that we are always
looking for products that will help increase compliance, decrease
liability, and improve patient outcomes in the medial marijuana
industry, says Dr. Orlando Florete, MD, President of the American
Medical Marijuana Physicians Association. We believe that CanaPass
and its U.S. equivalents will be a benefit to physicians that
recommend alternative medical treatments in a safe and legal
environment.
Based in Clermont, Florida, AMMPAs mission is to support
physicians and patients who utilize medical marijuana as a
treatment alternative in the setting of a legally indicated
diagnosis. With over 650 physician members, AMMPA is a leader in
providing physicians with comprehensive support in education,
compliance and legal advocacy.
We are honored to receive AMMPAs recognition of the CanaPass
systems unparalleled focus on transparency and compliance, says
Jade Green, Vice-President, Sales and Marketing, at Alternate
Health. This endorsement represents another step forward as we aim
to set the standard in cannabis-specific medical software across
North America.
The CanaPass system is a cloud-based software platform that
manages the end-to-end transactions involved with providing safe
access to medical cannabis for eligible patients. CanaPasss key
features include the ability to view a patients purchase history
and monitor a patients response to cannabis products, allowing
physicians to make recommendation adjustments to improve overall
patient outcomes.
We are excited to see one of Alternate Healths key technology
assets receiving recognition from such an influential and respected
organization of physicians, says Dr. Michael Murphy, CEO of
Alternate Health. The CanaPass system solves a number of challenges
in the field of medical cannabis, setting us up for new
opportunities in this rapidly developing sector.
A copy of the American Medical Marijuana Physicians Association
official endorsement letter can be accessed via the link below.
http://alternatehealth.ca/docs/AMMPA_Endorsement.pdf
About Alternate Health Corp.
Alternate Health Corp. (CSE:AHG,
OTCQB:AHGIF) is an international
medical cannabis company that uses best in class technology,
research, education, production and laboratories to increase the
awareness, regulatory compliance, and appropriate usage of
cannabinoids in modern medical practices. The company is
strategically positioned in all facets of the medical cannabis
value chain through the innovative integration of proprietary
technology and know-how, acquisitions and partnerships, deep direct
knowledge of, and experience with improving patient outcomes, and
management expertise.
Alternate Health is well positioned to reinvest internal
operating cash flow in its platform over the long term, creating an
attractive investment profile for its shareholders. The Company is
headquartered in San Antonio, Texas, with operations in Los Angeles
and Toronto.
For more information about Alternate Health Corp., visit
www.alternatehealth.ca
Investor Relations Contact:
Nancy Goertzen, CPIR
n.goertzen@alternatehealth.ca
1.604.512.7122
Neither the CSE nor its Regulation Services Provider (as that
term is defined in the policies of the CSE) accepts responsibility
for the adequacy or accuracy of this release. Statements included
in this announcement, including statements concerning our plans,
intentions and expectations, which are not historical in nature are
intended to be, and are hereby identified as "forward-looking
statements". Forward-looking statements may be identified by words
including "anticipates", "believes", "intends", "estimates",
"expects" and similar expressions. The Company cautions readers
that forward-looking statements, including without limitation those
relating to the Companys future operations, business prospects and
financing plans, are subject to certain risks and uncertainties
that could cause actual results to differ materially from those
indicated in the forward-looking statements
